In-Vitro Fertilization Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global In-vitro Fertilization Market, By Instrument

7.1.  In-vitro Fertilization Market, By Instrument Type, 2020-2027

7.1.1.    Disposable Devices

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Culture Media

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Capital Equipment

7.1.3.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global In-vitro Fertilization Market, By Procedure Type

8.1.  In-vitro Fertilization Market, By Procedure Type, 2020-2027

8.1.1.    Fresh Donor

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Frozen Donor

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Fresh Non-donor

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Frozen Non-donor

8.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global In-vitro Fertilization Market, By End-use

9.1.  In-vitro Fertilization Market, By End-use, 2020-2027

9.1.1.    Fertility Clinics

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Hospitals & Others Setting

9.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global In-vitro Fertilization Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Instrument (2016-2027)

10.1.2.  Market Revenue and Forecast, By Procedure Type (2016-2027)

10.1.3.  Market Revenue and Forecast, By End-use (2016-2027)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.1.4.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.1.4.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.1.5.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.1.5.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Instrument (2016-2027)

10.2.2.  Market Revenue and Forecast, By Procedure Type (2016-2027)

10.2.3.  Market Revenue and Forecast, By End-use (2016-2027)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.2.4.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.2.4.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.2.5.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.2.5.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.2.6.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.2.6.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.2.7.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.2.7.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Instrument (2016-2027)

10.3.2.  Market Revenue and Forecast, By Procedure Type (2016-2027)

10.3.3.  Market Revenue and Forecast, By End-use (2016-2027)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.3.4.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.3.4.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.3.5.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.3.5.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.3.6.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.3.6.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.3.7.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.3.7.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Instrument (2016-2027)

10.4.2.  Market Revenue and Forecast, By Procedure Type (2016-2027)

10.4.3.  Market Revenue and Forecast, By End-use (2016-2027)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.4.4.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.4.4.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.4.5.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.4.5.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.4.6.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.4.6.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.4.7.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.4.7.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Instrument (2016-2027)

10.5.2.  Market Revenue and Forecast, By Procedure Type (2016-2027)

10.5.3.  Market Revenue and Forecast, By End-use (2016-2027)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.5.4.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.5.4.3.      Market Revenue and Forecast, By End-use (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Instrument (2016-2027)

10.5.5.2.      Market Revenue and Forecast, By Procedure Type (2016-2027)

10.5.5.3.      Market Revenue and Forecast, By End-use (2016-2027)

Chapter 11.  Company Profiles

11.1.              OvaScience

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              EMD Serono Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Vitrolife AB

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Irvine Scientific

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Cook Medical Inc

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Cooper Surgical Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Genea Biomedx

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Thermo Fisher Scientific Inc.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Progyny, Inc.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Boston IVF

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms